FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Provectus Biopharmaceuticals Announces Immunology Data on PV-10 in Colon Cancer to Be Presented at 11th Annual ASC Meeting
January 22, 2016
Provectus Biopharmaceuticals Confirms First Patients Dosed in Trials of PV-10 for Melanoma
January 12, 2016
Provectus Biopharmaceuticals, Inc. to Present at Biotech Showcase™ 2016 on Wednesday January 13, 2016 at 3:30 PM Pacific Time
December 16, 2015
Provectus Biopharmaceuticals Reports Immune Mechanism of Action Data for Pv-10 Presented at Society for Immunotherapy of Cancer Annual Meeting Authored by Researchers at Moffitt Cancer Center
November 05, 2015
Provectus Biopharmaceuticals Will Hold Its 2015 Third Quarter Business Update Conference Call on Thursday, November 5, 2015, at 5 PM Eastern Standard Time
October 20, 2015
Provectus Biopharmaceuticals Reports Publication of Review Paper on PV-10 Tumor Ablation and Immune Stimulation
September 29, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here